Pfizer said it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool
said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool .
"The world knows by now that access to COVID-19 medical tools needs to be guaranteed for everyone, everywhere, if we really want to control this pandemic," said Yuanqiong Hu, MSF Senior Legal Policy Adviser. "We are extremely pleased to have another weapon in our armoury to protect people from the ravages of COVID-19," Charles Gore, Executive Director of the Medicines Patent Pool, said in an interview.
Pfizer will waive royalties on sales in low-income countries. It will also waive them in the other countries covered by the agreement as long as COVID-19 remains classified as a public health emergency of international concern by the World Health Organization.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Read more »
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Read more »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Read more »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Read more »
Labor Groups Press for Biden’s Covid-19 Vaccine Mandate to Go FurtherThree labor organizations have filed petitions asking the Biden administration to review its Covid-19 vaccine mandate, with some indicating the policy is too limited in applying to only large businesses
Read more »